Citation Impact
Citing Papers
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
2005 StandoutScience
Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma
2007
Expression of HIV-1 Envelope Glycoproteins by Semliki Forest Virus Vectors
1993
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Untangling the ErbB signalling network
2001 Standout
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments
2005
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
HER-2/neu Protein: A Target for Antigen-Specific Immunotherapy of Human Cancer
1997
Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression
2013
EGFR Antagonists in Cancer Treatment
2008 Standout
ErbB-targeted therapeutic approaches in human cancer
2003
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
2016 Standout
Cooperative Inhibition of Renal Cancer Growth by Anti-Epidermal Growth Factor Receptor Antibody and Protein Kinase A Antisense Oligonucleotide
1998
Epidermal growth factor receptor tyrosine kinase
1994
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer
2003
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Ribosome-inactivating proteins from plants
1993
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma
2001
Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates
2001
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Stem cells find their niche
2001 StandoutNature
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
1999
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan
1999
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
2014
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors
2002
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
Malignant Gliomas in Adults
2008 Standout
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism
1999
HIV as the cause of AIDS
1996 StandoutNobel
The Biology of Hair Follicles
1999 Standout
Oxidative stress as a therapeutic target in globoid cell leukodystrophy
2012
A Natural ErbB4 Isoform That Does Not Activate Phosphoinositide 3-Kinase Mediates Proliferation but Not Survival or Chemotaxis
2000
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
1997
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations
2006
Antibacterial drug discovery in the resistance era
2016 StandoutNature
DNA‐binding properties of novel cis‐ and trans platinum‐based anticancer agents in 2 human ovarian carcinoma cell lines
1995
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
2004
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
2000
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
2006 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
HGF/SF: a potent cytokine for mammary growth, morphogenesis and development
1995
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Type 1 growth factor receptors: an overview of recent developments
1995
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
1986 Standout
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.
1995
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
2003
The extracellular matrix geneFrem1is essential for the normal adhesion of the embryonic epidermis
2004 StandoutNobel
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
[16] Preparation of antibody—toxin conjugates
1985
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
1995
Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.
1995
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Paralogous mouse Hox genes, Hoxa9, Hoxb9, and Hoxd9, function together to control development of the mammary gland in response to pregnancy
1999 StandoutNobel
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
1993
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
1998 StandoutScience
Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy
2003
Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
2002
Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice
2005
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies
1994
Antibody-directed enzyme prodrug therapy (ADEPT): a review
1997
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
Multiple event activation of a generic prodrug trigger by antibody catalysis
1999 StandoutNobel
Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
2001
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
An antibody-desferrioxamine conjugate labelled with 67Ga
1986
Challenges of Antibacterial Discovery
2011
Absorption by water increases fluorescence image contrast of biological tissue in the shortwave infrared
2018 StandoutNobel
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
1998
Redesigning Nature's Poisons to Create Anti-Tumor Reagents
1987 Science
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Plakoglobin Suppresses Epithelial Proliferation and Hair Growth in Vivo
2000 StandoutNobel
Nucleotide sequence of cloned cDNA coding for preproricin
1985
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
2004 Standout
Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
2000
Works of Christopher Dean being referenced
Methodology for selection of human antibodies to membrane proteins from a phage-display library
1997
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.
1994
Clinical radioimmunolocalization with a rat monoclonal antibody directed against c-erbB-2
1994
Detailed investigation of the diagnostic value in tumour histopathology of ICR.2, a new monoclonal antibody to epithelial membrane antigen
1990
Plasma Infusions into Porcine Cerebral White Matter Induce Early Edema, Oxidative Stress, Pro-Inflammatory Cytokine Gene Expression and DNA Fragmentation: Implications for White Matter Injury with Increased Blood- Brain-Barrier Permeability
2005
Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer
1996
Peptide deformylase as an antibacterial target: a critical assessment
2006
Brk, a Breast Tumor-derived Non-receptor Protein-tyrosine Kinase, Sensitizes Mammary Epithelial Cells to Epidermal Growth Factor
1996
Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in Vitro
1991
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer
1993
The chondroitin sulfate proteoglycan NG2 is a tumour-specific antigen on the chemically induced rat chondrosarcoma HSN
1994
Targeting of cells expressing wild‐type EGFR and type‐III mutant EGFR (EGFRvIII) by anti‐EGFR MAb ICR62: A two‐pronged attack for tumour therapy
2003
Two erbB-4 transcripts are expressed in normal breast and in most breast cancers
1998
Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction
1993
THE RECEPTOR FOR EGF AND ITS LIGANDS - EXPRESSION, PROGNOSTIC VALUE AND TARGET FOR THERAPY IN CANCER (REVIEW)
1994
Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agent
1985
THE GROWTH-RESPONSE OF HUMAN TUMOR-CELL LINES EXPRESSING THE EGF RECEPTOR TO TREATMENT WITH EGF AND OR MABS THAT BLOCK LIGAND-BINDING
1993
Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
1994
Ricin B chain converts a non‐cytotoxic antibody‐ricin A chain conjugate into a potent and specific cytotoxic agent
1983
Immunological detection of DNA damage caused by melphalan using monoclonal antibodies.
1987